They suggest that the intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance dependent on a slow-cycling state in dormant or slow-cycling disseminated tumor cells in bone marrow. Here, CXCR4 is linked to neoplasm.